Signet Financial Management’s United Therapeutics UTHR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.39M	Sell	10,781 -159	-1%	-$79.2K	0.72%	41
2025 Q4	$5.33M	Sell	10,940 -36	-0.3%	-$16.8K	0.6%	51
2025 Q3	$4.6M	Buy	10,976 +59	+0.5%	+$19.8K	0.53%	58
2025 Q2	$3.14M	Buy	10,917 +22	+0.2%	+$6.58K	0.39%	82
2025 Q1	$3.36M	Buy	10,895 +79	+0.7%	+$27.1K	0.45%	74
2024 Q4	$3.82M	Buy	10,816 +103	+1%	+$37.9K	0.49%	65
2024 Q3	$3.84M	Buy	10,713 +413	+4%	+$140K	0.49%	64
2024 Q2	$3.28M	Buy	+10,300	New	+$2.73M	0.44%	74
2018 Q4	–	Sell	-35,877	Closed	-$4.59M	–	809
2018 Q3	$4.59M	Sell	35,877 -1,296	-3%	-$160K	0.8%	41
2018 Q2	$4.21M	Sell	37,173 -1,043	-3%	-$115K	0.74%	53
2018 Q1	$4.29M	Buy	+38,216	New	+$4.85M	0.77%	52